Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 1, 2009, Pages 46-50

  Ellington, Mathew J ^a   Ganner, Mark ^a   Warner, Marina ^a   Cookson, Barry D ^a   Keams, Angela M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Community; MRSA; PVL

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; MACROLIDE; METICILLIN; MINOCYCLINE; NEOMYCIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PROTEIN AGR; PROTEIN SCCMEC; PROTEIN SPA; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; UNITED KINGDOM;

EID: 77950345591     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp386     Document Type: Article

References (11)

1. Witte W, Cuny C, Klare I et al. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Int J Med Microbiol 2008; 298: 365-77.
2. Morgan MS. Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 2007; 30: 289-96.
3. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 2006; 12 Suppl 1: 9-15.
4. Diep BA, Chambers HF, Graber CJ et al. Emergence of multidrugresistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148: 249-57.
5. Kourbatova EV, Halvosa JS, King MD et al. Emergence of communityassociated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005; 33: 385-91.
6. Takano T, Higuchi W, Otsuka T et al. Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan. Antimicrob Agents Chemother 2008; 52: 837-45.
7. Ellington MJ, Perry C, Ganner M et al. Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis 2009; 28: 1113-21.
8. Goering RV, Shawar RM, Scangarella NE et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol 2008; 46: 2842-7.
9. Afroz S, Kobayashi N, Nagashima S et al. Genetic characterization of Staphylococcus aureus isolates carrying Panton-Valentine leukocidin genes in Bangladesh. Jpn J Infect Dis 2008; 61: 393-6.
10. Neela V, Ehsanollah GR, Zamberi S et al. Prevalence of Panton- Valentine leukocidin genes among carriage and invasive Staphylococcus aureus isolates in Malaysia. Int J Infect Dis 2009; 13: e131-2.
11. Health Protection Agency. Guidance on the Diagnosis and Management of PVL-Associated Staphylococcus aureus Infections (PVL-SA) in the UK. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1218699411960 (17 September 2009, date last accessed).